Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family

Biochemical and Biophysical Research Communications

Volumn 300, Issue 4, 2003, Pages 972-979

  Liu, Yongzhong ^a   Li, Jinjun ^a   Zhang, Fengrui ^a   Qin, Wenxin ^a   Yao, Genfu ^a   He, Xianghuo ^a   Xue, Peng ^a   Ge, Chao ^a   Wan, Dafang ^a   Gu, Jianren ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

Author keywords

Ankyrin repeat; ASB; Chromosome 12q13; Elongin B C complex; SOCS box

Indexed keywords

ANKYRIN; PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; COMPUTER ANALYSIS; EXON; GENE MAPPING; GENETIC ANALYSIS; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRON; LUNG CANCER; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

EID: 0037462953     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02971-6     Document Type: Article

References (20)

1. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signaling. Nature. 387:1997;917-921.
2. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
3. Frantsve J., Schwaller J., Sternberg D.W., Kutok J., Gilliland D.G. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21:2001;3547-3557.
4. Nicholson S.E., Hilton D.J. The SOCS proteins: a new family of negative regulators of signal transduction. J. Leukoc. Biol. 63:1998;665-668.
5. Kamizono S., Hanada T., Yasukawa H., Minoguchi S., Kato R., Minoguchi M., Hattori K., Hatakeyama S., Yada M., Morita S., Kitamura T., Kato H., Nakayama K., Yoshimura A. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276:2001;12530-12538.
6. Kamura T., Sato S., Haque D., Liu L., Kaelin W.G.J., Conaway R.C., Conaway J.W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:1998;3872-3881.
7. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
8. Nicola N.A., Greenhalgh C.J. The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action. Exp. Hematol. 28:2000;1105-1112.
9. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1:1998;619-625.
10. Kohroki J., Fujita S., Itoh N., Yamada Y., Imai H., Yumoto N., Nakanishi T., Tanaka K. ATRA-regulated Asb-2 gene induced in differentiation of HL-60 leukemia cells. FEBS Lett. 505:2001;223-228.
11. Guibal F.C., Moog-Lutz C., Smolewski P., Gioia Y.D., Darzynkiewicz Z., Lutz P.G., Cayre Y.E. ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J. Biol. Chem. 277:2002;218-224.
12. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:2001;29-35.
13. Wu B.Y., Woffendin C., Duckett C.S., Ohno T., Nabel G.J. Regulation of human retroviral latency by the NF-. κ B/I κ B family: inhibition of human immunodeficiency virus replication by I κ B through a Rev-dependent mechanism Proc. Natl. Acad. Sci. USA. 92:1995;1480-1484.
14. Kile B.T., Metcalf D., Mifsud S., DiRago L., Nicola N.A., Hilton D.J., Alexander W.S. Functional analysis of Asb-1 using genetic modification in mice. Mol. Cell. Biol. 21:2001;6189-6197.
15. Duan D.R., Pause A., Burgess W.H., Aso T., Chen D.Y., Garrett K.P., Conaway R.C., Conaway J.W., Linehan W.M., Klausner R.D. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science. 269:1995;1402-1406.
16. Aso T., Haque D., Barstead R.J., Conaway R.C., Conaway J.W. The inducible Elongin A elongation activation domain: structure, function and interaction with the Elongin BC complex. EMBO J. 15:1996;5557-5566.
17. Stebbins C.E., Kaelin W.G.J., Pavletich N.P. Structure of the VHL-Elongin C-Elongin B complex: implications for VHL tumor suppressor function. Science. 284:1999;455-461.
18. Berg J.N., Gallione C.J., Stenzel T.T., Johnson D.W., Allen W.P., Schwartz C.E., Jackson C.E., Porteous M.E., Marchuk D.A. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am. J. Hum. Genet. 61:1997;60-67.
19. Wong K.F., So C.C., Yu P.H. Translocation (12; 17) (q13; q23) in de novo acute myeloid leukemia with trilineage myelodysplasia. Cancer Genet. Cytogenet. 114:1999;159-161.
20. Lesniewska B.B., Zhao J., Speel E.J., Biraima A.M., Turina M., Komminoth P., Heitz P.U. Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery. Virchows Arch. 438:2001;57-65.